The stranded cruise ships are finally moving again, but TUI’s relief is proving short-lived. After more than 50 days trapped in Persian Gulf ports, vessels incl ...
Infineon shares surge 48% in a month, driven by AI data center demand, automotive chip recovery, and a 50% efficiency gain from its GenAI test engineering project.
Gerresheimer's 50% stock rebound belies a severe accounting scandal, BaFin investigations, creditor lifeline, and shareholder ...
Alphabet stock surges 23% ahead of Q1 earnings as analysts bet big on AI cloud growth, but $175B capex raises questions about ...
Global oil supply plunges 10M bpd as Iran conflict seals Strait of Hormuz. OMV shares rise 21% YTD but face Q1 headwinds, ...
Micron posts $12.20 EPS vs $8.60 consensus, revenue surges to $23.86B, as CEO pushes Congress to restrict Chinese rivals via ...
The investment case for hydrogen has long been framed around decarbonisation. That story is being rewritten. Rising ...
VanEck's TDIV ETF nears 52-week high as earnings season, ECB rate decision, and US GDP data loom. Top holdings like Verizon and Roche report, with financials and energy in focus.
The stars are not aligning for Barrick Mining. While the Canadian gold giant posted a near-$5 billion profit last year and ...
German defence sensor maker Hensoldt sees orders surge 62% but shares near 52-week lows amid Chinese export restrictions and capacity expansion costs.
ServiceNow shares rebound after 18% rout, driven by strong Q1 revenue and AI traction, but Armis acquisition margins and 39% ...
BioNTech's personalized mRNA cancer vaccine posts striking 6-year survival data in pancreatic cancer, while its CureVac subsidiary files a new patent lawsuit against Moderna.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results